Eric Lofkosfky and his family, are very well known in Chicago for founding Groupon and the venture capital company, LightBank. Eric and his wife Liz made the headlines of several news announcements in the recent months for their various philanthropic acts. The Lofkosfky couple committed a considerable amount of their wealth to the Giving Pledge charity foundation. In 2012, the Lofkofsky’s Family organization donated 4.6 million to various agencies in the Chicago region in support of endeavors in health, education and the arts. The Lofkosfky foundation also supports leading global and state organizations such as Human Rights Watch, the Ann & Robert H. Lurie children’s hospital, charter schools, and Waterkeepers Alliance. Although the foundation has not stated its stand in support of the environment, it contributed $250,000 to Waterkeepers Alliance to support the protection of streams, rivers, and coastlines around the globe. Eric is actively in the process of innovating better and more efficient cancer treatments, an activity which perfectly aligns with his humanitarian mission.
Besides Eric Lofkofsky’s involvement in philanthropy, he is the co-owner and chief executive officer of Tempus. Eric joined Tempus after leaving Groupon and earning a name on the Forbes list as a billionaire. He stated that the journey towards creating a better cancer treatment though technology is a long but beneficial journey. Tempus is a technology inclined firm that specializes in building an international library that processes molecular and clinical data to avail the information to the public. Tempus allows physicians to provide cancer patients with customized treatment through an interactive analytical and machine learning model. It provides services in data sequencing, molecular analysis, and therapeutic data to enable a medical practitioner to make real-time and accurate decisions. Eric Lofkosfky. Tempus currently has an employee count of 29, including the former director of HighGround, Hunter Lane, Anil Saldanha and Ryan Fukushima. Eric commented that Tempus personalized care for cancer patients is a breakthrough in the continuing search for a cancer cure. He revealed that Tempus tailors a patient’s medication, dose, regimen, and sequence. Eric is a former student of the University of Michigan, where he earned his Juris Doctor and Michigan law school.
See also tempus.com